Adaptimmune Therapeutics
ADAP
#10409
Rank
A$20.29 M
Marketcap
A$0.07658
Share price
0.00%
Change (1 day)
-81.78%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Adaptimmune Therapeutics CIK: 0001621227

Thumbnail Adaptimmune Therapeutics 10-K Annual Report

10-K Annual Report 2025-03-24

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report

10-K Annual Report 2024-03-06

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report

10-K Annual Report 2023-03-06

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report

10-K Annual Report 2022-03-14

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report

10-K Annual Report 2021-02-25

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report

10-K Annual Report 2020-02-27

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report

10-K Annual Report 2019-02-27

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report

10-K Annual Report 2018-03-15

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report

10-K Annual Report 2017-03-13

Language: English

View Annual Report (10-K)